tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MREO Stock Latest News

Regulatory De‑Risking Boosts Setrusumab Outlook and Supports Buy Rating on Mereo BioPharma
RatingsRegulatory De‑Risking Boosts Setrusumab Outlook and Supports Buy Rating on Mereo BioPharma
2d ago
MREO
Mereo BioPharma management to meet virtually with Cantor Fitzgerald
PremiumThe Fly
Mereo BioPharma management to meet virtually with Cantor Fitzgerald
13d ago
MREO
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
1M ago
QSI
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
1M ago
BTQ
ITB
Mereo BioPharma’s Q3 2025: Progress in Rare Disease Pipeline
PremiumCompany Announcements
Mereo BioPharma’s Q3 2025: Progress in Rare Disease Pipeline
1M ago
MREO
Positive Outlook for Mereo Biopharma: Buy Rating on Promising Setrusumab Developments and Strong Financial Position
PremiumRatingsPositive Outlook for Mereo Biopharma: Buy Rating on Promising Setrusumab Developments and Strong Financial Position
1M ago
MREO
Positive Outlook for Mereo Biopharma Group Plc Driven by Strong Clinical Progress and Strategic Initiatives
Premium
Ratings
Positive Outlook for Mereo Biopharma Group Plc Driven by Strong Clinical Progress and Strategic Initiatives
1M ago
MREO
Mereo BioPharma reports Q3 EPS (1c), consensus 0c
Premium
The Fly
Mereo BioPharma reports Q3 EPS (1c), consensus 0c
1M ago
MREO
Mereo BioPharma price target raised to $8 from $7 at JPMorgan
PremiumThe Fly
Mereo BioPharma price target raised to $8 from $7 at JPMorgan
4M ago
MREO
Mereo Biopharma Group Plc: Strategic Advancements and Promising Developments Justify Buy Rating
PremiumRatings
Mereo Biopharma Group Plc: Strategic Advancements and Promising Developments Justify Buy Rating
4M ago
MREO
Promising Future for Mereo Biopharma: Buy Rating Backed by Positive Trial Prospects and Strong Market Position
PremiumRatings
Promising Future for Mereo Biopharma: Buy Rating Backed by Positive Trial Prospects and Strong Market Position
4M ago
MREO
Mereo BioPharma Reports Increased Losses Amid Strategic Focus
PremiumCompany Announcements
Mereo BioPharma Reports Increased Losses Amid Strategic Focus
4M ago
MREO
Positive Outlook for Mereo Biopharma Group Plc: Buy Rating Supported by Strong Financial Position and Promising Study Results
PremiumRatingsPositive Outlook for Mereo Biopharma Group Plc: Buy Rating Supported by Strong Financial Position and Promising Study Results
4M ago
MREO
Mereo BioPharma reports Q2 EPS (2c), consensus (1c)
Premium
The Fly
Mereo BioPharma reports Q2 EPS (2c), consensus (1c)
4M ago
MREO
Mereo BioPharma sees cash runway into 2027
Premium
The Fly
Mereo BioPharma sees cash runway into 2027
4M ago
MREO
Mereo BioPharma’s Setrusumab Study: A Potential Breakthrough for Osteogenesis Imperfecta
PremiumCompany Announcements
Mereo BioPharma’s Setrusumab Study: A Potential Breakthrough for Osteogenesis Imperfecta
5M ago
MREO
Mereo BioPharma’s Setrusumab Study Update: Implications for Investors
PremiumCompany Announcements
Mereo BioPharma’s Setrusumab Study Update: Implications for Investors
5M ago
MREO
Trump declares 50% tariff on copper, Brazil: Morning Buzz
PremiumThe Fly
Trump declares 50% tariff on copper, Brazil: Morning Buzz
6M ago
F
BE
Mereo BioPharma price target lowered to $5 from $7 at Needham
PremiumThe Fly
Mereo BioPharma price target lowered to $5 from $7 at Needham
6M ago
MREO
Mereo BioPharma’s Phase 3 Study Progresses Smoothly
PremiumCompany AnnouncementsMereo BioPharma’s Phase 3 Study Progresses Smoothly
6M ago
8K
MREO
Mereo Biopharma Group Plc: Buy Rating Maintained Amid Challenges and Promising Study Outcomes
Premium
Ratings
Mereo Biopharma Group Plc: Buy Rating Maintained Amid Challenges and Promising Study Outcomes
6M ago
MREO
Promising Outlook for Mereo Biopharma’s Setrusumab Amid Phase 3 Trial Advances and Market Potential
Premium
Ratings
Promising Outlook for Mereo Biopharma’s Setrusumab Amid Phase 3 Trial Advances and Market Potential
6M ago
MREO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >